Status:
COMPLETED
An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical Practice
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Non-Squamous Non-Small Cell Lung Cancer
Eligibility:
All Genders
65+ years
Brief Summary
This prospective, observational study will assess the effectiveness and safety of Avastin (bevacizumab) as 1st line therapy in elderly patients with advanced non-squamous non-small cell lung cancer in...
Eligibility Criteria
Inclusion
- Adult patients, \>= 65 years of age
- Diagnosis of advanced non squamous Non-Small Cell Lung Carcinoma (nsNSCLC, stage IIIB or IV) for whom the physician has decided to initiate a treatment with Avastin combined with chemotherapy as 1st line therapy
- Having received oral and written information about the study, and having signed a written consent form
Exclusion
- Participation in a cancer clinical trial with an investigational medicinal product other than this study
- Patient previously treated with Avastin
- Patient under supervision or guardianship
Key Trial Info
Start Date :
July 25 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 20 2018
Estimated Enrollment :
279 Patients enrolled
Trial Details
Trial ID
NCT01893268
Start Date
July 25 2013
End Date
March 20 2018
Last Update
May 14 2018
Active Locations (88)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Du Docteur Calabet; Cromg
Agen, France, 47000
2
Ch Du Pays D Aix; Pneumologie
Aix-en-Provence, France, 13616
3
Poly Parc Rambot La Provencale; Chimiotherapie Ambulatoire
Aix-en-Provence, France, 13617
4
Cabinet Medical
Amiens, France, 80090